Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Keywords:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideAbstract
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Pakistan Journal of Kidney Diseases

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
